undamentalytics Newsletter
Sign in

Beyond Air, Inc. (XAIR) stock

Add to watchlist

Add holding +

NASDAQ: XAIR Nasdaq Health Care Equipment Next results ~November 11, 2026

D Fundamentals grade

Beyond Air, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in March.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$10

Price-to-sales vs peers

Base case. Range ~$10–$51. Sales per share times peers' typical price-to-sales; used only when earnings are negative.

Price vs value

No Buy/Hold/Sell rating is issued: only 1 valuation models apply; a rating needs 3.

Beyond Air, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders3 buying, 0 selling6 purchases and 0 sales by directors and officers, last 12 monthsInsider trades
  • Funds1 adding, 0 cuttingOf 0 active managers that changed their stake, 0 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Beyond Air files

Where Beyond Air stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $8m, up 60.7% on a year earlier, slower than the 107.3% growth a quarter earlier. Free-cash-flow margin rose to -255.0% from -752.2% a year earlier. Operating margin widened to -364.8% from -806.7%. The diluted share count is up 125.9% on a year earlier, which dilutes existing holders. It passes 1 of our 3 financial-health checks. Our price-to-sales vs peers value is $10.68 a share, against a share price of $2.43.

Source: 10-Q filed August 13, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 11, 2026 (estimated)

Beyond Air, Inc.'s trailing-twelve-month revenue grew 60.7% year on year, with a free-cash-flow margin of -255.0%. Where it stands out: change in share count of -99.0% ranks 1 of 115 health care equipment companies we cover. Where it lags: change in growth rate of -46.5pp ranks 125 of 129 health care equipment companies we cover.

Current signal Revenue growth decelerating: TTM revenue growth slowed to 60.7% (-46.5pp vs the prior quarter), the 5th consecutive quarterly slowdown.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 60.7% over the last 12 months, against a median of 9.1% for health care equipment companies we cover.
  • Margins widening. Operating margin is up 441.9 points on a year ago.
  • Shrinking share count. Diluted shares fell 99.0% in a year, so each share owns more of the business.
  • Net cash. Cash exceeds long-term debt by $0.0bn.

Things to watch

  • Growth slowing. The growth rate is 46.5 points lower than a quarter earlier.
  • Loss-making. Operating margin is -364.8%: costs exceed revenue.
  • Burning cash. Free cash flow was -255.0% of revenue over the last 12 months.
  • Heavy stock-based pay. Stock pay equals 61.7% of revenue, against a median of 6.1% for health care equipment companies we cover: a real cost that cash-flow figures leave out.
  • Volatile shares. Over the past year the shares showed annualised volatility of 181% and a beta of 0.5 against the S&P 500.
  • Below peers: gross margin. Gross margin of 4.2% ranks 116 of 123 health care equipment companies we cover (median 61.9%).

Latest results: FY2027 Q1

Filed August 13, 2026
Revenue
$2m, up 0.5% on a year earlier
Share reaction
-11.4% in the first session after the results on October 8, 2026, against +0.2% for the S&P 500
Next report
November 11, 2026

Beyond Air's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-1.3%
  • 1 week+3.3%
  • 1 month-21.6%
  • This year-84.8%
  • 1 year-94.6%
  • 5 years-100.0%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$7.7M
Operating margin
-364.8%
Net margin
-435.7%
EPS (TTM, diluted)
$-109.48

Growth

Revenue growth
+60.7%
Change in growth rate
−46.5 pts
Share count change
−99.0%

Cash

Free cash flow (TTM)
-$19.6M
FCF margin
-255.0%
Stock pay % of revenue
61.7%

Earnings

Last results
October 8, 2026
Next results (est.)
January 4, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Leadership
  3. Results
  4. Announcement
  5. Agreement
  6. Governance

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Beyond Air, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: only 1 valuation models apply; a rating needs 3.

Valuation models

We value Beyond Air, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 9.5%: the 10-year Treasury yield (4.9%) plus a beta of 1.01 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. — Does not apply: revenue and margins don't support a positive value
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: no positive earnings in the latest twelve months
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: the model gives no positive value
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. ~$10 ~$12–$51 Included, half weight
Combined value Weighted average of the models that apply: the primary model (revenue-to-maturity model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$10 ~$10–$51 1 model

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Beyond Air, Inc. with Health Care Equipment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 201920202021202420252026
Share price$1920.00$3200.00$2200.00$696.00$109.20$13.80
Market value$1.6bn$3.7bn$4.0bn$2.3bn$370m$115m
+ Net debt (− = net cash)−$1m−$20m−$30m$6m$7m$15m
Enterprise value$1.6bn$3.7bn$3.9bn$2.3bn$377m$129m
Multiples
Price / sales n/mn/mn/mn/m99.8x14.9x
Price / earnings ——————
Price / free cash flow n/m—————
EV / EBITDA ——————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 11, 2026, after the close. Analysts expect revenue of $2m for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$26.68 +90% $8m +121%
Next −$8.04 +70% $17m +104%

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −28.6% on 90 days ago. In the last 30 days, 0 analysts raised Beyond Air, Inc.'s forecast and 0 cut it.

Consensus EPS forecast Beyond Air, Inc., last 90 days
−$40.00 −$30.00 −$20.00 −$10.00 $0.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$37.40 Current fiscal year, 60 days ago: −$37.40 Current fiscal year, 30 days ago: −$26.70 Current fiscal year, 7 days ago: −$26.70 Current fiscal year, Now: −$26.68 −$26.68 Next fiscal year, 30 days ago: −$8.04 Next fiscal year, 7 days ago: −$8.04 Next fiscal year, Now: −$8.04 −$8.04

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$37.40−$8.04
60 days ago −$37.40−$8.04
30 days ago −$26.70−$8.04
7 days ago −$26.70$0.00
Now −$26.68$0.00

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2025 −$26.40 −$30.60 −15.9%
Mar 2025 −$48.80 −$36.00 +26.2%
Dec 2024 −$64.00 −$60.00 +6.2%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

2 analysts, Oct 2026
Buy2100%
Hold00%
Sell00%

Monthly trend

  1. Oct 2026112
  2. Sep 2026112
  3. Aug 202611
  4. Jul 2026112

Counts of recommendations published by analysts covering Beyond Air, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
6.1%
of tradable shares
Days to cover
0.74
at average volume
Short interest, 1 month
+1%
to October 15, 2026
Held by institutions
8%
of shares
Held by insiders
20.8%
of shares
Employees
54
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
XAIR+79%−31%−70%−82%−90%−85%
Industry peers (median)−9%−37%−8%−19%−16%−13%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
XAIR67%42%33%33%25%9%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
XAIR−46%−52%−82%−86%−92%−95%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since June 12, 2018: 100% from November 26, 2021 to October 23, 2026. Getting back needed a 298656% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$2.09 – $43.80
From 52-week high
−95.0%
vs 50-day average
−25.9%
vs 200-day average
−78.6%
Volatility (1 year)
181%
Beta vs S&P 500
0.53

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
3 up, 9 down
typical move ±6.9%
After a week
2 up, 10 down
typical move ±11.7%
After a month
0 up, 11 down
typical move ±23.8%
Results releasedNext dayS&P 500 next day5 days21 days
October 8, 2026 −11.4% +0.2% −13.0% —
August 18, 2026 −8.8% −0.5% −12.8% −46.1%
June 26, 2026 −2.5% +0.9% −8.0% −42.8%
February 13, 2026 +5.9% +0.2% −1.0% −21.1%
November 14, 2025 −6.3% −0.9% −8.4% −35.9%
August 18, 2025 −1.3% −0.6% −1.7% −1.7%
June 18, 2025 −18.6% −0.2% −42.8% −41.8%
February 14, 2025 −2.2% +0.3% −12.4% −23.5%
November 18, 2024 +4.8% +0.8% +9.0% −14.2%
August 9, 2024 +2.6% +0.5% +12.6% −6.7%
June 27, 2024 −15.3% −0.2% −6.9% −2.4%
February 16, 2024 −2.9% −1.0% −11.7% −25.4%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Beyond Air, Inc. in five measures

Fundamentals grade D
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Beyond Air, Inc.
$0 $2M $4M $6M $8M FY21 Q3 FY25 Q1 FY25 Q4 FY27 Q1 Revenue (TTM), FY21 Q3: $530.8K Revenue (TTM), FY21 Q4: $873.2K Revenue (TTM), FY24 Q4: $1.2M Revenue (TTM), FY25 Q1: $1.8M Revenue (TTM), FY25 Q2: $2.3M Revenue (TTM), FY25 Q3: $3M Revenue (TTM), FY25 Q4: $3.7M Revenue (TTM), FY26 Q1: $4.8M Revenue (TTM), FY26 Q2: $5.8M Revenue (TTM), FY26 Q3: $6.9M Revenue (TTM), FY26 Q4: $7.7M Revenue (TTM), FY27 Q1: $7.7M $7.7M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY21 Q3 $530.8K
FY21 Q4 $873.2K
FY24 Q4 $1.2M
FY25 Q1 $1.8M
FY25 Q2 $2.3M
FY25 Q3 $3M
FY25 Q4 $3.7M
FY26 Q1 $4.8M
FY26 Q2 $5.8M
FY26 Q3 $6.9M
FY26 Q4 $7.7M
FY27 Q1 $7.7M
Revenue growth, TTM YoY Beyond Air, Inc.
-100% 0% 100% 200% 300% FY21 Q4 FY26 Q1 FY26 Q3 FY27 Q1 Revenue growth, TTM YoY, FY21 Q4: -37.2% Revenue growth, TTM YoY, FY25 Q4: 219.7% Revenue growth, TTM YoY, FY26 Q1: 168.2% Revenue growth, TTM YoY, FY26 Q2: 147.7% Revenue growth, TTM YoY, FY26 Q3: 129.0% Revenue growth, TTM YoY, FY26 Q4: 107.3% Revenue growth, TTM YoY, FY27 Q1: 60.7% 60.7%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY21 Q4 -37.2%
FY25 Q4 219.7%
FY26 Q1 168.2%
FY26 Q2 147.7%
FY26 Q3 129.0%
FY26 Q4 107.3%
FY27 Q1 60.7%
Operating margin (TTM) Beyond Air, Inc.
-6000% -4000% -2000% 0% FY21 Q3 FY25 Q1 FY25 Q4 FY27 Q1 Operating margin (TTM), FY21 Q3: -4226.7% Operating margin (TTM), FY21 Q4: -2544.1% Operating margin (TTM), FY24 Q4: -5436.3% Operating margin (TTM), FY25 Q1: -3405.0% Operating margin (TTM), FY25 Q2: -2391.5% Operating margin (TTM), FY25 Q3: -1654.0% Operating margin (TTM), FY25 Q4: -1202.1% Operating margin (TTM), FY26 Q1: -806.7% Operating margin (TTM), FY26 Q2: -575.7% Operating margin (TTM), FY26 Q3: -419.5% Operating margin (TTM), FY26 Q4: -378.2% Operating margin (TTM), FY27 Q1: -364.8% -364.8%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY21 Q3 -4226.7%
FY21 Q4 -2544.1%
FY24 Q4 -5436.3%
FY25 Q1 -3405.0%
FY25 Q2 -2391.5%
FY25 Q3 -1654.0%
FY25 Q4 -1202.1%
FY26 Q1 -806.7%
FY26 Q2 -575.7%
FY26 Q3 -419.5%
FY26 Q4 -378.2%
FY27 Q1 -364.8%
FCF margin (TTM) Beyond Air, Inc.
-6000% -4000% -2000% 0% FY21 Q3 FY25 Q1 FY25 Q4 FY27 Q1 FCF margin (TTM), FY21 Q3: -3732.9% FCF margin (TTM), FY21 Q4: -2351.1% FCF margin (TTM), FY24 Q4: -5328.6% FCF margin (TTM), FY25 Q1: -3178.0% FCF margin (TTM), FY25 Q2: -2356.4% FCF margin (TTM), FY25 Q3: -1597.8% FCF margin (TTM), FY25 Q4: -1190.3% FCF margin (TTM), FY26 Q1: -752.2% FCF margin (TTM), FY26 Q2: -450.7% FCF margin (TTM), FY26 Q3: -319.6% FCF margin (TTM), FY26 Q4: -249.6% FCF margin (TTM), FY27 Q1: -255.0% -255.0%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY21 Q3 -3732.9%
FY21 Q4 -2351.1%
FY24 Q4 -5328.6%
FY25 Q1 -3178.0%
FY25 Q2 -2356.4%
FY25 Q3 -1597.8%
FY25 Q4 -1190.3%
FY26 Q1 -752.2%
FY26 Q2 -450.7%
FY26 Q3 -319.6%
FY26 Q4 -249.6%
FY27 Q1 -255.0%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-KT, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2019 Mar 2019 2020 Mar 2020 2021 Mar 2021 2024 Mar 2024 2025 Mar 2025 2026 Mar 2026 LTM Jun 2026
Income
Revenue 8 1 1 1 4 8 8
Gross profit — — — −1 −2 0 0
EBITDA −3 −18 −22 −61 −42 −26 −25
Operating income −3 −18 −22 −63 −45 −29 −28
Net income −7 −20 −23 −60 −47 −33 −33
Diluted EPS −$7.70 −$0.89 −$12.70 −$0.91 −$13.77 −$4.01 —
Growth (year on year)
Revenue — −82.0% −37.2% +32.8% +219.7% +107.3% +60.7%
Margins
Gross margin — — — −112.8% −44.9% 3.3% 4.2%
EBITDA margin −38.8% <−999% <−999% <−999% <−999% −337.9% −323.1%
Operating margin −39.6% <−999% <−999% <−999% <−999% −378.2% −364.8%
Net margin −84.9% <−999% <−999% <−999% <−999% −433.0% −435.7%
Free-cash-flow margin 16.6% <−999% <−999% <−999% <−999% −249.6% −255.0%
Cash flow
Cash from operations 1 −15 −20 −56 −38 −18 −19
Capital spending 0 0 1 6 6 1 1
Free cash flow 1 −15 −21 −62 −44 −19 −20
Stock-based pay 2 4 5 21 9 5 5
Free cash flow after stock pay −1 −19 −25 −83 −53 −24 −24
Balance sheet
Cash 1 20 35 11 5 7 6
Total debt 0 0 4 18 12 22 22
Net debt (negative = net cash) −1 −20 −30 6 7 15 17
Diluted shares — 1m 2m 3m 3m 8m —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 3 checks passed · June 30, 2026
What it owns · $33m
Short-term assets $23mLonger-term assets $10m
What it owes, and who funded it · $32m
Short-term liabilities $7mLonger-term liabilities $23mShareholders' equity $2m
  • Short-term assets cover short-term liabilities $23m of assets due within a year against $7m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $23m short-term assets against $23m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of −$28m against $4m of interest.

From Beyond Air, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
−99.0%
year over year
R&D spending
118.6%
of revenue
Sales & admin spending
250.4%
of revenue
Days sales outstanding
54 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in health care equipment
Last 12 months unless stated XAIR IVF NNNN NUWE MLSS NMTC Median
Revenue, last 12 months $8m $8m $9m $9m $9m $9m $99m
Revenue growth, last 12 months 60.7% 13.8% 5.6% 8.4% 3.7% 42.8% 9.2%
Revenue growth, 3-year average 122.7% 85.6% — 2.8% −1.9% 94.9% 13.5%
Revenue growth, latest quarter 0.5% 16.7% — 14.1% 22.3% 16.3% 10.2%
Gross margin 4.2% 53.6% 87.2% 69.7% 70.2% 55.6% 61.2%
Operating margin −364.8% −78.7% 66.7% −142.9% −43.6% −83.4% −8.5%
Operating margin, 3-year average <−999% −97.0% — −138.4% −66.8% −160.3% −17.9%
Net margin −435.7% −92.3% 74.1% −125.6% −44.0% −78.6% −12.0%
Cash from operations / revenue −241.5% −63.3% −77.9% −138.3% −6.8% −74.5% −1.9%
Free-cash-flow margin −255.0% −63.3% — −139.7% −7.0% −75.6% −3.9%
Free-cash-flow margin, 3-year average <−999% −77.4% — −126.7% −53.1% −142.5% −7.0%
Stock pay / revenue 61.7% 64.3% — 1.0% 10.3% 14.9% 6.1%
Change in share count −99.0% 26.6% 3.3% 5.4% 5.9% 41.1% 4.0%

Median of all 134 companies we cover in health care equipment. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

134 health care equipment companies
Measure Company Peer median Rank
Revenue growth Growth 60.7% 9.1% 9 of 129
Change in growth rate Growth -46.5pp -0.6pp 125 of 129
Gross margin Profitability 4.2% 61.9% 116 of 123
Operating margin Profitability -364.8% -8.3% 113 of 132
Net margin Profitability -435.7% -12.0% 114 of 133
Free-cash-flow margin Cash generation -255.0% -3.4% 111 of 128
Stock pay as % of revenue Cash generation 61.7% 6.1% 110 of 123
Change in share count Balance sheet -99.0% 3.3% 1 of 115
Days sales outstanding Balance sheet 54 days 57 days 53 of 118

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$7
Institutions reporting
1
Positions opened / closed
1 / 0

Top buyers and sellers, Q2 2026: 1 institutions bought and 0 sold ; the biggest buyer was Sbi Securities Co., Ltd (+15 shares) . See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Sbi Securities Co., Ltd. $7 0K 100.0% —

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Beyond Air, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $287,349 6 trades by 3 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $287,349 net buying
Insider Date Trade Shares Price Value
Lin Yi-Chien 10% owner October 13, 2026 Buy 2,607 $2.21 $5,761
Lin Yi-Chien 10% owner October 1, 2026 Buy 15,393 $2.80 $43,100
Lin Yi-Chien 10% owner September 30, 2026 Buy 2,000 $2.71 $5,420
Lin Yi-Chien 10% owner September 29, 2026 Buy 3,000 $2.69 $8,070
Moorhead Daniel J Chief Financial Officer July 29, 2026 Buy 4,340 $5.76 $24,998
Goodman Robert Scott Chief Executive Officer July 29, 2026 Buy 34,722 $5.76 $199,999

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around January 4, 2027 estimated from the company's past filing pattern, not announced

  • October 8, 2026
  • August 18, 2026
  • June 26, 2026
  • February 13, 2026
  • November 14, 2025
  • August 18, 2025

Recent SEC filings

Data status

When each part of this page on Beyond Air, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Beyond Air, Inc. in brief

What does Beyond Air, Inc. do?
Beyond Air, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in March.
What is Beyond Air, Inc.'s stock ticker?
Beyond Air, Inc. trades under the ticker XAIR on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Beyond Air, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Beyond Air, Inc. reported revenue of $7.7M, 60.7% higher than a year earlier, according to its SEC filings.
What is Beyond Air, Inc.'s free cash flow?
Beyond Air, Inc.'s free-cash-flow margin is -255.0% of revenue over the trailing twelve months, ranking 111 of the 128 health care equipment companies we cover.
What is Beyond Air, Inc.'s market cap?
On March 31, 2026, Beyond Air, Inc.'s market capitalisation was about $115M and net debt of $14.9M. Market figures come from third-party market data and may be delayed.
Who are Beyond Air, Inc.'s competitors?
In our Health Care Equipment peer group, the companies closest to Beyond Air, Inc. are Invo Fertility, Inc., Anbio Biotechnology, Nuwellis, Inc., Milestone Scientific Inc. and Neuroone Medical Technologies Corp. The side-by-side comparison below sets their revenue, margins and growth against Beyond Air, Inc.'s.
Are insiders buying or selling Beyond Air, Inc. stock?
Over the last 12 months, Beyond Air, Inc.'s directors and officers reported 6 open-market purchases and 0 sales on Form 4. The insider trading page charts every trade.
When is Beyond Air, Inc.'s next earnings date?
Around November 11, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Beyond Air, Inc. announces its own schedule.